Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05755711 · ClinicalTrials.gov registry record
Equity in Modifying Plaque Of WomEn With UndeRtreated Calcified Coronary Artery Disease
A clinical trial of Coronary Artery Disease, sponsored by Shockwave Medical.
- Active
- Registry status
- 399
- Enrollment target
- 20
- Study locations
NCT05755711 is a study of Coronary Artery Disease that is active but no longer recruiting, run by Shockwave Medical. The registered enrollment target is 399 participants, below the 1,285-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (69% lower). The trial reports 20 study locations across 11 states.
The verdict
NCT05755711, a study of Coronary Artery Disease, is active but no longer recruiting, sponsored by Shockwave Medical.
- ACTIVE NOT RECRUITING
- Registry status
- 399 participants
- Enrollment target
- 20
- Study locations
Study Summary
Post-market, prospective, multi-center, single-arm observational study to generate real-world clinical evidence associated with coronary IVL in a population of female subjects with calcified coronary artery disease.
Conditions Studied
Interventions
- DEVICE Shockwave Medical Coronary IVL System
Study Locations (20)
California
- Loma Linda University Health - Loma Linda
- Good Samaritan Hospital - Los Angeles
- Kaiser Permanente - San Francisco Medical Center - San Francisco
- Stanford University - Stanford
Georgia
- Emory Hospital - Atlanta
- Piedmont Heart Institute - Atlanta
- Northside Hospital - Atlanta
New York
- NYU Langone Health - Brooklyn
- NYU Langone Health - New York
- Columbia University Medical Center - New York
Florida
- Morton Plant Hospital - Clearwater
- Tallahassee Research Institute - Tallahassee
Massachusetts
- Massachusetts General Hospital - Boston
- Brigham and Women's Hospital - Boston
Colorado
- South Denver Cardiology Associates, P.C - Littleton
Connecticut
- Yale New Haven Hospital - New Haven
Illinois
- Northwestern University - Evanston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 399 participants |
| Start Date | 2023-05-03 |
| Est. Completion | 2028-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05755711
The ClinicalTrials.gov registry entry for NCT05755711 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 399 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,285-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (69% lower). The listed sponsor is Shockwave Medical, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Coronary Artery Disease appearing as the primary indexed condition, and to 1 intervention - of which Shockwave Medical Coronary IVL System is the first listed.
NCT05755711 reports 20 study locations spanning 11 distinct geographic areas - top geographies include California, Georgia, New York.
Frequently Asked Questions
What is clinical trial NCT05755711 about?
NCT05755711 is a clinical study titled "Equity in Modifying Plaque Of WomEn With UndeRtreated Calcified Coronary Artery Disease". Post-market, prospective, multi-center, single-arm observational study to generate real-world clinical evidence associated with coronary IVL in a population of female subjects with calcified coronary artery disease.
What is the current status of trial NCT05755711?
This trial is currently active not recruiting. The enrollment target is 399 participants. The study started on 2023-05-03. Estimated completion is 2028-04.
What conditions does trial NCT05755711 study?
This clinical trial studies the following conditions: Coronary Artery Disease.
What interventions are being tested in trial NCT05755711?
The interventions under investigation include: Shockwave Medical Coronary IVL System (DEVICE).
Who is sponsoring clinical trial NCT05755711?
This trial is sponsored by Shockwave Medical, which has 13 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05755711 being conducted?
This trial has 20 study locations across California, Colorado, Connecticut, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Coronary Artery Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation
RECRUITING · NA
-
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
RECRUITING · NA
-
PET/CT* vs. Cardiac CT for Detecting Coronary Atherosclerotic Disease [*PET: Positron Emission Tomography; CT: Computed Tomography]
RECRUITING · NA
-
Factors Affect Outcomes in Cardiovascular Surgery
RECRUITING
-
Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Change in Cardiovascular Health
RECRUITING · NA
-
Impact of Disclosing Coronary Artery Disease Polygenic Risk Score on Cardiovascular Health
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.